Tag: IMA PDT

Everest Medicines Announces Full Approval of NEFECON® in Taiwan

SHANGHAI, Aug. 6, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing,...

SIFI Announces Reimbursement Approval for AKANTIOR® in Spain

AKANTIOR® is anticipated to become available to Spanish patients on 1st August Spain is the first Country in the world to approve the pricing and...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsIMA PDT

CALIFORNIA RISES: GENESIS DEEPENS COMMITMENT TO PACIFIC PALISADES RECOVERY

David Kruzner Joins Trianz | Concierto as Global Transformation Advisory Services Leader

Vanguard Announces Cash Distributions for the Vanguard ETFs

Tag: IMA PDT

Everest Medicines Announces Full Approval of NEFECON® in Taiwan

SIFI Announces Reimbursement Approval for AKANTIOR® in Spain

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us